Today: 20 May 2026
UOB share price stalls near S$39 as traders brace for Feb. 24 results
5 February 2026
1 min read

UOB share price stalls near S$39 as traders brace for Feb. 24 results

Singapore, Feb 5, 2026, 15:01 SGT — Regular session

  • UOB shares saw little movement in afternoon trading following a subdued week to date
  • Investors are making moves ahead of UOB’s full-year results, due Feb. 24
  • Broker calls are still divided following the wave of downgrades and upgrades in January

Shares of United Overseas Bank (UOB) held steady on Thursday, as traders hesitated to drive the stock higher following a strong January rally that pushed it to record highs.

The stock slipped 0.03% to S$38.58 by mid-afternoon, bouncing between S$38.45 and S$38.72 earlier. Volume hovered around 1.1 million shares, per data.

This is crucial with UOB’s key date looming in under three weeks. The bank’s results usually reset expectations for dividends, buybacks, and loan-loss buffers across Singapore’s banks.

The stock remains near recent highs. In such a tight trading range, even minor tweaks in guidance can have a big impact.

UOB announced in an SGX filing that it will publish its full-year 2025 financial results on Feb. 24, ahead of market open.

Investors are zeroing in on two key factors: net interest margin—the gap between what banks earn from loans versus what they pay on deposits—and the provisions banks must set aside for potential loan losses.

Broker opinions are split. JPMorgan cut UOB to “underweight” late last month, sticking with a S$34 target price. On the flip side, Macquarie bumped its rating to “outperform” and set a S$41 target, The Business Times reported.

UOB has flagged the risk of margin pressure ahead. Back in November, the bank flagged its 2026 net interest margin would likely fall short of 2025’s forecast, following a third-quarter profit drop driven by a spike in credit provisions, Reuters reported.

The broader market edged lower on Thursday. Singapore shares dipped as investors digested corporate updates, including the latest earnings from Singapore Exchange, The Straits Times reported.

Risks remain two-sided. Should margins shrink faster than expected or credit costs hold firm, bank shares could reverse sharply — particularly following recent gains.

UOB will release its full-year results on Feb. 24, ahead of the market open. Investors will be watching closely for updates on margin forecasts, credit conditions, and the 2026 shareholder return strategy.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
KKR stock jumps after-hours as $5.2 billion data-center deal lands before earnings
Previous Story

KKR stock jumps after-hours as $5.2 billion data-center deal lands before earnings

Anglo American share price slips after copper output drop, 2026 guidance cut
Next Story

Anglo American share price slips after copper output drop, 2026 guidance cut

Go toTop